Document Detail

Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
MedLine Citation:
PMID:  7448106     Owner:  NLM     Status:  MEDLINE    
1. Blood clearances of lignocaine and indocyanine green together with indocyanine green half-lives were measured in 17 post-myocardial infarct patients (one patient was studied twice) between 8 h and 36 h after starting intravenous lignocaine infusions for the treatment of cardiac arrhythmias. 2. Mean +/- s.d. values of lignocaine clearance (ml min-1 kg-1) were higher in patients without heart failure (11.8 +/- 2.6, n = 9) than in those with heart failure (7.2 +/- 1.9, n = 9) (P < 0002). 3. Clearances of lignocaine and indocyanine green were not correlated but lignocaine clearance was directly related to the reciprocal of indocyanine green half-life (rs = 0.67, P < 0.01). 4. In eight patients who received both lignocaine and indocyanine green and in a further five patients received only lignocaine and whose lignocaine infusions lasted 24h or more, a 25% rise in lignocaine concentrations was observed between 8-12h and 24-28h. 5. The mean +/- s.d. post-infusion terminal half-life of lignocaine in four patients whose lignocaine infusions lasted 30h or longer was 7.2 +/- 2.1 h. 6. Heart failure was associated with greater changes in lignocaine kinetics than in indocyanine green kinetics. 72% of the variance between observed and predicted lignocaine clearances could be accounted for by multiple linear regression analysis incorporating indocyanine green half-life and the presence or absence of heart failure. Indocyanine green half-life contributed only 17% of the variance indicating that by itself it is of limited value in predicting lignocaine requirements. 7. Lignocaine kinetics during and after prolonged intravenous infusion were not predicted by data obtained after intravenous bolus injection. 8. A lowering of lignocaine dosage may be clinically desirable in the presence of heart failure and if an infusion lasts longer than 24 h.
N D Bax; G T Tucker; H F Woods
Related Documents :
24262616 - Clinical outcome after crush versus culotte stenting of coronary artery bifurcation les...
8104206 - Abnormalities of baroreflex control in heart failure.
25477356 - Computer-assisted volumetric measurement of core infarct volume in pediatric patients: ...
18388526 - Biologics and heart failure in rheumatoid arthritis: are we any wiser?
8897676 - Effect of the potassium-channel opener nicorandil as an adjunct to cardioplegia on myoc...
7087526 - Aortico-left ventricular tunnel: collective review.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  10     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1980 Oct 
Date Detail:
Created Date:  1981-03-24     Completed Date:  1981-03-24     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  353-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Heart Failure / metabolism*
Indocyanine Green / metabolism*
Lidocaine / metabolism*
Metabolic Clearance Rate
Middle Aged
Myocardial Infarction / metabolism*
Regression Analysis
Reg. No./Substance:
137-58-6/Lidocaine; 3599-32-4/Indocyanine Green

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Obstetric anaesthesia and Ehlers-Danlos syndrome.
Next Document:  Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.